BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 2893412)

  • 41. Single-dose 8-OH-DPAT pretreatment does not induce tachyphylaxis to the 5-HT release-reducing effect of 5-HT1A autoreceptor agonists.
    Hjorth S
    Eur J Pharmacol; 1991 Jun; 199(2):237-42. PubMed ID: 1835441
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increase in the isolation-induced social behavioural deficit by agonists at 5-HT1A receptors.
    Francès H; Khidichian F; Monier C
    Neuropharmacology; 1990 Feb; 29(2):103-7. PubMed ID: 1970424
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Repeated treatment with the 5-HT1A receptor agonist, ipsapirone, does not affect 8-OH-DPAT- and stress-induced increases in plasma adrenaline levels in the rat.
    Baudrie V; Chaouloff F
    Eur J Pharmacol; 1991 Jun; 198(2-3):129-35. PubMed ID: 1830845
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 8-OH-DPAT elicits feeding and not chewing: evidence from liquid diet studies and a diet choice test.
    Dourish CT; Clark ML; Iversen SD
    Psychopharmacology (Berl); 1988; 95(2):185-8. PubMed ID: 2970649
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Involvement of 5-HT1A- and alpha 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralin.
    Marsden CA; Martin KF
    Br J Pharmacol; 1986 Oct; 89(2):277-86. PubMed ID: 2430656
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Benzodiazepines and putative 5-HT1A agonists increase hypertonic saline consumption in rehydrating rats.
    Cooper SJ; Desa A
    Pharmacol Biochem Behav; 1987 Oct; 28(2):187-91. PubMed ID: 2825218
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuroendocrine responses to the serotonin2 agonist DOI are differentially modified by three 5-HT1A agonists.
    Li Q; Rittenhouse PA; Levy AD; Alvarez Sanz MC; Van de Kar LD
    Neuropharmacology; 1992 Oct; 31(10):983-9. PubMed ID: 1359439
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 5-HT1A receptor agonists buspirone and gepirone attenuate apomorphine-induced aggressive behaviour in adult male Wistar rats.
    Pruus K; Skrebuhhova-Malmros T; Rudissaar R; Matto V; Allikmets L
    J Physiol Pharmacol; 2000 Dec; 51(4 Pt 2):833-46. PubMed ID: 11220492
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serotonin does not mediate anxiolytic effects of buspirone in the fear-potentiated startle paradigm: comparison with 8-OH-DPAT and ipsapirone.
    Davis M; Cassella JV; Kehne JH
    Psychopharmacology (Berl); 1988; 94(1):14-20. PubMed ID: 2894698
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neurochemical changes in pigeon cerebrospinal fluid during chronic administration of buspirone or 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
    Nader MA; Barrett JE
    Pharmacol Biochem Behav; 1989 Jan; 32(1):227-32. PubMed ID: 2471984
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Behavioural and biochemical consequences following activation of 5HT1-like and GABA receptors in the dorsal raphé nucleus of the rat.
    Higgins GA; Bradbury AJ; Jones BJ; Oakley NR
    Neuropharmacology; 1988 Oct; 27(10):993-1001. PubMed ID: 2467224
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 8-Hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) elicits eating in free-feeding rats by acting on central serotonin neurons.
    Bendotti C; Samanin R
    Eur J Pharmacol; 1986 Feb; 121(1):147-50. PubMed ID: 2937644
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alterations of central serotonin and dopamine turnover in rats treated with ipsapirone and other 5-hydroxytryptamine1A agonists with potential anxiolytic properties.
    Hamon M; Fattaccini CM; Adrien J; Gallissot MC; Martin P; Gozlan H
    J Pharmacol Exp Ther; 1988 Aug; 246(2):745-52. PubMed ID: 2457083
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characteristics of feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT).
    Dourish CT; Hutson PH; Curzon G
    Brain Res Bull; 1985 Oct; 15(4):377-84. PubMed ID: 2933126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Brainstem 5-hydroxytrytamine1A binding sites are not down-regulated by agonists which induce tolerance in the rat: myoclonus and other serotonergic behaviors.
    Murthy JN; Pranzatelli MR
    J Recept Res; 1992; 12(3):287-97. PubMed ID: 1387164
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Apparent hyperalgesic action of the 5-HT1A agonist, 8-OH-DPAT, in the rat reflects induction of spontaneous tail-flicks.
    Millan MJ; Bervoets K; Colpaert FC
    Neurosci Lett; 1989 Dec; 107(1-3):227-32. PubMed ID: 2533334
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 5-HT1A agonists and dopamine: the effects of 8-OH-DPAT and buspirone on brain-stimulation reward.
    Montgomery AM; Rose IC; Herberg LJ
    J Neural Transm Gen Sect; 1991; 83(1-2):139-48. PubMed ID: 1826841
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Single administration of 5-HT1A agonists decreases 5-HT1A presynaptic, but not postsynaptic receptor-mediated responses: relationship to antidepressant-like action.
    Kennett GA; Marcou M; Dourish CT; Curzon G
    Eur J Pharmacol; 1987 Jun; 138(1):53-60. PubMed ID: 2442002
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selective activation of 5HT1A receptors induces lower lip retraction in the rat.
    Berendsen HH; Jenck F; Broekkamp CL
    Pharmacol Biochem Behav; 1989 Aug; 33(4):821-7. PubMed ID: 2533357
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Discriminative stimulus properties of flesinoxan.
    Ybema CE; Slangen JL; Olivier B; Mos J
    Pharmacol Biochem Behav; 1990 Apr; 35(4):781-4. PubMed ID: 2140607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.